A Phase I Dose-Finding Study of Silybin Phosphatidylcholine (Milk Thistle) in Patients With Advanced Hepatocellular Carcinoma

THE SAFETY AND EFFICACY OF A SILYMARIN AND SELENIUM COMBINATION IN MEN AFTER RADICAL PROSTATECTOMY - A SIX MONTH PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL TRIAL

(2012) Ales Vidlar et al.   BIOMEDICAL PAPERS-OLOMOUC

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

(2012) Morris Sherman et al.   HEPATOLOGY

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

(2012) R. Lencioni et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy

(2012) Michael W. Fried   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score

(2011) A. Hollebecque et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation

(2011) Jessica Wagoner et al.   PLoS One

Sorafenib: Where do we go from here?

(2010) Abby B. Siegel et al.   HEPATOLOGY

A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)

(2009) Elena J. Ladas et al.   CANCER

Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

(2009) Roy L. Hawke et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Review: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies

(2009) Sonja K. Olsen et al.   Therapeutic Advances in Gastroenterology

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE